American Regent Email Format

PharmaceuticalsUnited States201-500 Employees

American Regent is a United States–based pharmaceutical manufacturer that concentrates on producing injectable medicines for the domestic market. Its product lineup has included FDA-approved injections such as Levocarnitine Injection and Sodium Phosphates Injection, both positioned as therapeutically equivalent to established references. The company maintains a workforce in the low hundreds and has pursued capacity growth, including a 2024 expansion of its manufacturing footprint in New Albany, Indiana. This expansion reflects the firm’s ongoing efforts to support domestic production of injectable therapies. American Regent serves healthcare providers and pharmaceutical partners within the United States, supporting manufacturing and supply of injectable products. In 2025, it partnered with OrthoTrophix on its DMOAD candidate TPX-100 for the U.S. market.

Sign up for free to view info

Company overview Employee directory